Supply chain map developed to track pharmaceutical ingredients

U.S. Pharmacopeia, an independent scientific organization, released a medicine supply map aiming to build visibility and identify which pharmaceutical ingredients are vulnerable to shortages, the organization said March 16. 

Advertisement

The map uses 40 external datasets and 250 million data points to “quantify risk and resilience” in the upstream pharmaceutical supply chain, the March 16 news release said. 

“USP’s Medicine Supply Map is an innovative early warning system to help identify ingredient and finished product at risk of shortage so providers, manufacturers and governments can take actions to help prevent the shortage from occurring,” said Ronald Piervincenzi, PhD, CEO of U.S. Pharmacopeia. “Without visibility into the medicine supply chain, preparing for the next crisis is not possible.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

From fragmentation to operational flow: Solving the healthcare workforce puzzle

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenters: Dr. Pat Hunt, QGendaAndrea Daugherty, MHA, CISSP, CHCIO, CDH-E, Arrowhead Regional Medical CenterElizabeth Lindsay-Wood, MBA, CHCIO, CDH-E, Moffitt Cancer CenterDeb Muro, El Camino HealthJohn Tejeda, D.H.A., MLS, MPAS, DFAAPA, LSSBB, FACHE, Vascular and Neuroscience Institute

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.